Published in Lancet Psychiatry on February 25, 2015
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry (2015) 2.44
Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry (2016) 1.40
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry (2015) 1.15
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry (2016) 1.02
Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01
New Clinically Relevant Findings about Violence by People with Schizophrenia. Can J Psychiatry (2016) 0.96
Cannabis and psychosis. Lancet Psychiatry (2015) 0.95
Perspective: Be clear about the real risks. Nature (2015) 0.93
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential. Neurotherapeutics (2015) 0.91
Cannabis and psychosis. Lancet Psychiatry (2015) 0.91
Cannabis and psychosis. Lancet Psychiatry (2015) 0.91
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed. Neuropsychopharmacology (2015) 0.87
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med (2015) 0.87
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry (2016) 0.82
Marijuana use trajectories during college predict health outcomes nine years post-matriculation. Drug Alcohol Depend (2015) 0.81
Cannabis and psychosis - Authors' reply. Lancet Psychiatry (2015) 0.80
Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs. Health Aff (Millwood) (2016) 0.79
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry (2017) 0.78
Weaving a Net of Neurobiological Mechanisms in Schizophrenia and Unraveling the Underlying Pathophysiology. Biol Psychiatry (2016) 0.78
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset. Behav Genet (2015) 0.78
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. JAMA Psychiatry (2017) 0.77
WHY NOT POT?: A Review of the Brain-based Risks of Cannabis. Innov Clin Neurosci (2016) 0.77
Recreational marijuana use impacts white matter integrity and subcortical (but not cortical) morphometry. Neuroimage Clin (2016) 0.76
A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users. Drug Alcohol Depend (2016) 0.76
The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil (2017) 0.76
Legalizing marijuana. J Psychiatry Neurosci (2016) 0.75
High-potency cannabis increases the risk of psychosis. Evid Based Ment Health (2016) 0.75
'Legal highs' - what's in a name? BJPsych Bull (2015) 0.75
Appraising the risks of reefer madness. Cerebrum (2015) 0.75
Patterns of marijuana and tobacco use associated with suboptimal self-rated health among US adult ever users of marijuana. Prev Med Rep (2017) 0.75
Potent questions about cannabis and mental health. Lancet Psychiatry (2015) 0.75
An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity. Neuropharmacology (2015) 0.75
New drugs in psychiatry: focus on new pharmacological targets. F1000Res (2017) 0.75
Is the medical use of cannabis a therapeutic option for children? Paediatr Child Health (2016) 0.75
Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth. J Adolesc Health (2017) 0.75
Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study. Soc Psychiatry Psychiatr Epidemiol (2017) 0.75
The Challenges of Projecting the Public Health Impacts of Marijuana Legalization in Canada Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts". Int J Health Policy Manag (2016) 0.75
Marijuana and acute health care contacts in Colorado. Prev Med (2017) 0.75
Variation in cannabis potency and prices in a newly-legal market: Evidence from 30 million cannabis sales in Washington State. Addiction (2017) 0.75
The effects of cannabis use on salience attribution: a systematic review. Acta Neuropsychiatr (2016) 0.75
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. Curr Addict Rep (2017) 0.75